New shoulder block could beat standard pain method

NCT ID NCT07668648

Recruiting now Symptom relief Sponsor: Ferit Yetik Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study compares two types of nerve blocks for pain after arthroscopic shoulder surgery. The standard block can sometimes cause temporary diaphragm paralysis. The newer block aims to provide similar pain relief with fewer risks. Eighty adults undergoing shoulder surgery will be randomly assigned to receive one of the two blocks, and their pain levels and opioid use will be tracked for 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Bupivacaine
What this could lead to: If this trial succeeds, it could point toward a safer, equally effective pain-blocking method for shoulder surgery, reducing complications like diaphragm paralysis.
What could go wrong: This is a small, early-stage trial (80 participants) comparing two procedures. The newer block may not prove as effective, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE PAIN SHOULDER ARTHROSCOPY

Contacts and locations

Locations

Bursa City Hospital
RECRUITING

Bursa, Nilüfer, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.